Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas.

Abstract excerpt

Medulloblastomas (MBs) account for 15% of brain tumors in children under the age of 15. To date, the overall 5-year survival rate for all children is only around 60%. Recent advances in cancer genomics have led to a fundamental change in medulloblastoma classification and is evolving along with the genomic discoveries, allowing to regularly reclassify this disease. The previous molecular classification defined 4...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cerebellar Neoplasms
• Share to Child
• Share to MYC gene